Skip to content
2000
Volume 32, Issue 1
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

The anti-aging effects of alpha-lipoic acid (αLA), a natural antioxidant synthesized in human tissues, have attracted a growing interest in recent years. αLA is a short-chain sulfur-containing fatty acid occurring in the mitochondria of all kinds of eukaryotic cells. Both the oxidized disulfide of αLA and its reduced form (dihydrolipoic acid, DHLA) exhibit prominent antioxidant function. The amount of αLA inside the human body gradually decreases with age resulting in various health disorders. Its lack can be compensated by supplying from external sources such as dietary supplements or medicinal dosage forms. The primary objectives of this study were the analysis of updated information on the latest two-decade research regarding the use of αLA from an anti-aging perspective. The information was collected from PubMed, Wiley Online Library, Scopus, ScienceDirect, SpringerLink, Google Scholar, and clinicaltrials.com. Numerous , , , and clinical studies revealed that αLA shows a protective role in biological systems by direct or indirect reactive oxygen/nitrogen species quenching. αLA demonstrated beneficial properties in the prevention and treatment of many age-related disorders such as neurodegeneration, metabolic disorders, different cancers, nephropathy, infertility, and skin senescence. Its preventive effects in case of Alzheimer's and Parkinson's diseases are of particular interest. Further mechanistic and clinical studies are highly recommended to evaluate the wide spectrum of αLA therapeutic potential that could optimize its dietary intake for prevention and alleviation disorders related to aging.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673300496240416114827
2024-04-19
2024-12-25
Loading full text...

Full text loading...

References

  1. BjørklundG. ShanaidaM. LysiukR. ButnariuM. PeanaM. SaracI. StrusO. SmetaninaK. ChirumboloS. Natural compounds and products from an anti-aging perspective.Molecules20222720708410.3390/molecules2720708436296673
    [Google Scholar]
  2. López-OtínC. BlascoM.A. PartridgeL. SerranoM. KroemerG. The hallmarks of aging.Cell201315361194121710.1016/j.cell.2013.05.03923746838
    [Google Scholar]
  3. KahramanC. Kaya BilecenogluD. SabuncuogluS. CankayaI.T. Toxicology of pharmaceutical and nutritional longevity compounds.Expert Rev. Mol. Med.202325e2810.1017/erm.2023.1837345424
    [Google Scholar]
  4. KenyonC.J. The genetics of ageing.Nature2010464728850451210.1038/nature0898020336132
    [Google Scholar]
  5. WangY. SunY. WangX. WangY. LiaoL. ZhangY. FangB. FuY. Novel antioxidant peptides from Yak bones collagen enhanced the capacities of antiaging and antioxidant in Caenorhabditis elegans.J. Funct. Foods20228910493310.1016/j.jff.2022.104933
    [Google Scholar]
  6. ShenP. YueY. ZhengJ. ParkY. Caenorhabditis elegans: A convenient in vivo model for assessing the impact of food bioactive compounds on obesity, aging, and Alzheimer’s disease.Annu. Rev. Food Sci. Technol.20189112210.1146/annurev‑food‑030117‑01270929261338
    [Google Scholar]
  7. BjørklundG. ShanaidaM. LysiukR. AntonyakH. KlishchI. ShanaidaV. PeanaM. Selenium: An antioxidant with a critical role in anti-aging.Molecules20222719661310.3390/molecules2719661336235150
    [Google Scholar]
  8. OleshchukO. IvankivY. FalfushynskaH. MudraA. LisnychukN. Hepatoprotective effect of melatonin in toxic liver injury in rats.Medicina (Kaunas)201955630410.3390/medicina5506030431238587
    [Google Scholar]
  9. QuispeC. Cruz-MartinsN. MancaM.L. ManconiM. SytarO. HudzN. ShanaidaM. KumarM. TaheriY. MartorellM. Sharifi-RadJ. PintusG. ChoW.C. Nano-Derived therapeutic formulations with curcumin in inflammation-related diseases.Oxid. Med. Cell. Longev.2021202111510.1155/2021/314922334584616
    [Google Scholar]
  10. GasmiA. MujawdiyaP.K. LysiukR. ShanaidaM. PeanaM. Gasmi BenahmedA. BeleyN. KovalskaN. BjørklundG. Quercetin in the prevention and treatment of coronavirus infections: A focus on SARS-CoV-2.Pharmaceuticals (Basel)2022159104910.3390/ph1509104936145270
    [Google Scholar]
  11. TripathiA.K. RayA.K. MishraS.K. BishenS.M. MishraH. KhuranaA. Molecular and therapeutic insights of alpha-lipoic acid as a potential molecule for disease prevention.Rev. Bras. Farmacogn.202333227228710.1007/s43450‑023‑00370‑136778891
    [Google Scholar]
  12. ShayK.P. MoreauR.F. SmithE.J. SmithA.R. HagenT.M. Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential.Biochim. Biophys. Acta, Gen. Subj.20091790101149116010.1016/j.bbagen.2009.07.02619664690
    [Google Scholar]
  13. KobayashiY. ItoR. SaitoK. Enantiomeric determination of α-Lipoic acid in urine by LC/MS/MS.J. Pharm. Biomed. Anal.201916643543910.1016/j.jpba.2019.01.04230731341
    [Google Scholar]
  14. SacchettoL. MonzaniD. ApaE. LovatoA. CaragliV. GherpelliC. PalmaS. GenoveseE. NociniR. The effect of alpha-lipoic acid in the treatment of chronic subjective tinnitus through the tinnitus handicap inventory scores.Audiology Res.202313448449410.3390/audiolres1304004337489379
    [Google Scholar]
  15. GorącaA. Huk-KolegaH. PiechotaA. KleniewskaP. CiejkaE. SkibskaB. Lipoic acid – biological activity and therapeutic potential.Pharmacol. Rep.201163484985810.1016/S1734‑1140(11)70600‑422001972
    [Google Scholar]
  16. ArmaganI. BayramD. CandanI.A. YigitA. CelikE. ArmaganH.H. UğuzA.C. Effects of pentoxifylline and alpha lipoic acid on methotrexate-induced damage in liver and kidney of rats.Environ. Toxicol. Pharmacol.20153931122113110.1016/j.etap.2015.04.00325912852
    [Google Scholar]
  17. BossoM. HaddadD. Al MadhounA. Al-MullaF. Targeting the metabolic paradigms in cancer and diabetes.Biomedicines202412121110.3390/biomedicines1201021138255314
    [Google Scholar]
  18. CronanJ.E. Progress in the enzymology of the mitochondrial diseases of lipoic acid requiring enzymes.Front. Genet.20201151010.3389/fgene.2020.0051032508887
    [Google Scholar]
  19. TóthF. CsehE.K. VécseiL. Natural molecules and neuroprotection: Kynurenic acid, pantethine and α-Lipoic acid.Int. J. Mol. Sci.202122140310.3390/ijms2201040333401674
    [Google Scholar]
  20. PackerL. WittE.H. TritschlerH.J. Alpha-lipoic acid as a biological antioxidant.Free Radic. Biol. Med.199519222725010.1016/0891‑5849(95)00017‑R7649494
    [Google Scholar]
  21. RochetteL. GhibuS. RichardC. ZellerM. CottinY. VergelyC. Direct and indirect antioxidant properties of α-Lipoic acid and therapeutic potential.Mol. Nutr. Food Res.201357111412510.1002/mnfr.20120060823293044
    [Google Scholar]
  22. VenigallaM. SonegoS. GyengesiE. SharmanM.J. MünchG. Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer’s disease.Neurochem. Int.201695637410.1016/j.neuint.2015.10.01126529297
    [Google Scholar]
  23. KanE. AliciÖ. KanE.K. AyarA. Effects of alpha-lipoic acid on retinal ganglion cells, retinal thicknesses, and VEGF production in an experimental model of diabetes.Int. Ophthalmol.20173761269127810.1007/s10792‑016‑0396‑z27848046
    [Google Scholar]
  24. KoloverouE. TambalisK. PanagiotakosD.B. GeorgousopoulouE. ChrysohoouC. SkoumasI. TousoulisD. StefanadisC. PitsavosC. ATTICA study group Moderate physical activity reduces 10-year diabetes incidence: The mediating role of oxidative stress biomarkers.Int. J. Public Health201863229730510.1007/s00038‑017‑1052‑829128918
    [Google Scholar]
  25. DemirR. YaylaM. AkpinarE. CakirM. CalikogluC. OzelL. OzdemirG. MercantepeT. Protective effects of alpha-lipoic acid on experimental sciatic nerve crush injury in rats: Assessed with functional, molecular and electromicroscopic analyses.Int. J. Neurosci.20141241293594310.3109/00207454.2014.90237524617291
    [Google Scholar]
  26. KocaoğluS. AktaşO. ZengiO. TufanA. Karagöz GüzeyF. Effects of alpha lipoic acid on motor function and antioxidant enzyme activity of nerve tissue after sciatic nerve crush injury in rats.Turk Neurosurg.201710.5137/1019‑5149.JTN.18585‑16.129044452
    [Google Scholar]
  27. SandersL.L.O. de Souza MenezesC.E. Chaves FilhoA.J.M. de Almeida VianaG. FechineF.V. Rodrigues de QueirozM.G. Gonçalvez da Cruz FonsecaS. Mendes VasconcelosS.M. Amaral de MoraesM.E. GamaC.S. SeyboltS. de Moura CamposE. MacêdoD. Freitas de LucenaD. α-Lipoic acid as adjunctive treatment for schizophrenia.J. Clin. Psychopharmacol.201737669770110.1097/JCP.000000000000080029053478
    [Google Scholar]
  28. El MidaouiA. FantusI.G. Ait BoughrousA. CoutureR. Beneficial effects of alpha-lipoic acid on hypertension, visceral obesity, UCP-1 expression and oxidative stress in zucker diabetic fatty rats.Antioxidants201981264810.3390/antiox812064831888243
    [Google Scholar]
  29. NajafiN. MehriS. Ghasemzadeh RahbardarM. HosseinzadehH. Effects of alpha lipoic acid on metabolic syndrome: A comprehensive review.Phytother. Res.20223662300232310.1002/ptr.740635234312
    [Google Scholar]
  30. TripathyJ. TripathyA. ThangarajuM. SuarM. ElangovanS. α-Lipoic acid inhibits the migration and invasion of breast cancer cells through inhibition of TGFβ signaling.Life Sci.2018207152210.1016/j.lfs.2018.05.03929802942
    [Google Scholar]
  31. TürkezH. YıldırımÖ.Ç. ÖnerS. KadıA. MeteA. ArslanM.E. Şahinİ.O. YapçaÖ.E. MardinoğluA. Lipoic acid conjugated boron hybrids enhance wound healing and antimicrobial processes.Pharmaceutics202215114910.3390/pharmaceutics1501014936678778
    [Google Scholar]
  32. BjørklundG. AasethJ. CrisponiG. RahmanM.M. ChirumboloS. Insights on alpha lipoic and dihydrolipoic acids as promising scavengers of oxidative stress and possible chelators in mercury toxicology.J. Inorg. Biochem.201919511111910.1016/j.jinorgbio.2019.03.01930939378
    [Google Scholar]
  33. BarlettaM.A. MarinoG. SpagnoloB. BianchiF.P. FalapponeP.C.F. SpagnoloL. GattiP. Coenzyme Q10 + alpha lipoic acid for chronic COVID syndrome.Clin. Exp. Med.202223366767810.1007/s10238‑022‑00871‑835994177
    [Google Scholar]
  34. FeiM. XieQ. ZouY. HeR. ZhangY. WangJ. BoL. LiJ. DengX. Alpha-lipoic acid protects mice against concanavalin A-induced hepatitis by modulating cytokine secretion and reducing reactive oxygen species generation.Int. Immunopharmacol.201635536010.1016/j.intimp.2016.03.02327018751
    [Google Scholar]
  35. DörsamB. FahrerJ. The disulfide compound α-Lipoic acid and its derivatives: A novel class of anticancer agents targeting mitochondria.Cancer Lett.20163711121910.1016/j.canlet.2015.11.01926604131
    [Google Scholar]
  36. Castañeda-ArriagaR. Alvarez-IdaboyJ.R. Lipoic acid and dihydrolipoic acid. A comprehensive theoretical study of their antioxidant activity supported by available experimental kinetic data.J. Chem. Inf. Model.20145461642165210.1021/ci500213p24881907
    [Google Scholar]
  37. DurraniA.I. SchwartzH. NaglM. SontagG. Determination of free α-Lipoic acid in foodstuffs by HPLC coupled with CEAD and ESI-MS.Food Chem.201012041143114810.1016/j.foodchem.2009.11.045
    [Google Scholar]
  38. WollinS.D. JonesP.J.H. Alpha-lipoic acid and cardiovascular disease.J. Nutr.2003133113327333010.1093/jn/133.11.332714608040
    [Google Scholar]
  39. TakaishiN. YoshidaK. SatsuH. ShimizuM. Transepithelial transport of alpha-lipoic acid across human intestinal Caco-2 cell monolayers.J. Agric. Food Chem.200755135253525910.1021/jf063624i17536819
    [Google Scholar]
  40. LiY.X. KimY.J. ReddyC.K. LeeS.J. LimS.T. Enhanced bioavailability of alpha-lipoic acid by complex formation with octenylsuccinylated high-amylose starch.Carbohydr. Polym.2019219394510.1016/j.carbpol.2019.04.08231151539
    [Google Scholar]
  41. SalehiB. Berkay YılmazY. AntikaG. Boyunegmez TumerT. Fawzi MahomoodallyM. LobineD. AkramM. RiazM. CapanogluE. SharopovF. MartinsN. ChoW.C. Sharifi-RadJ. Insights on the use of α-Lipoic acid for therapeutic purposes.Biomolecules20199835610.3390/biom908035631405030
    [Google Scholar]
  42. DolininaE.S. AkimshevaE.Y. ParfenyukE.V. Development of novel silica-based formulation of α-Lipoic acid: Evaluation of photo and thermal stability of the encapsulated drug.Pharmaceutics202012322810.3390/pharmaceutics1203022832143535
    [Google Scholar]
  43. TrombaL. PerlaF. CarbottaG. ChiesaC. PacificoL. Effect of alpha-lipoic acid supplementation on endothelial function and cardiovascular risk factors in overweight/obese youths: a double-blind, placebo-controlled randomized trial.Nutrients201911237510.3390/nu1102037530759784
    [Google Scholar]
  44. GhibuS. CraciunC.E. RusuR. MorgovanC. MogosanC. RochetteL. GalA.F. DroncaM. Impact of alpha-lipoic acid chronic discontinuous treatment in cardiometabolic disorders and oxidative stress induced by fructose intake in rats.Antioxidants201981263610.3390/antiox812063631835800
    [Google Scholar]
  45. Theodosis-NobelosP. PapagiouvannisG. TzionaP. RekkaE.A. Lipoic acid. Kinetics and pluripotent biological properties and derivatives.Mol. Biol. Rep.20214896539655010.1007/s11033‑021‑06643‑z34420148
    [Google Scholar]
  46. CeylanlıD. ŞehirliA.Ö. GençosmanS. TeralıK. ŞahH. GülmezN. SayınerS. Protective effects of alpha-lipoic acid against 5-fluorouracil-induced gastrointestinal mucositis in rats.Antioxidants20221110193010.3390/antiox1110193036290656
    [Google Scholar]
  47. TibulloD. Li VoltiG. GiallongoC. GrassoS. TomassoniD. AnfusoC.D. LupoG. AmentaF. AvolaR. BramantiV. Biochemical and clinical relevance of alpha lipoic acid: Antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential.Inflamm. Res.2017661194795910.1007/s00011‑017‑1079‑628676917
    [Google Scholar]
  48. SchieberM. ChandelN.S. ROS function in redox signaling and oxidative stress.Curr. Biol.20142410R453R46210.1016/j.cub.2014.03.03424845678
    [Google Scholar]
  49. Rezaei ZonoozS. HasaniM. MorvaridzadehM. Beatriz PizarroA. HeydariH. YosaeeS. RezamandG. HeshmatiJ. Effect of alpha-lipoic acid on oxidative stress parameters: A systematic review and meta-analysis.J. Funct. Foods20218710477410.1016/j.jff.2021.104774
    [Google Scholar]
  50. MottolaF. SantonastasoM. IovineC. RossettiC. RongaV. RoccoL. DNA damage in human amniotic cells: Antigenotoxic potential of curcumin and α-lipoic acid.Antioxidants2021107113710.3390/antiox1007113734356370
    [Google Scholar]
  51. ParkD. LimJ.W. KimH. α-Lipoic acid inhibits apoptosis by suppressing the loss of Ku proteins in Helicobacter pylori-infected human gastric epithelial cells.Nutrients20221415320610.3390/nu1415320635956382
    [Google Scholar]
  52. Vig-VargaE. BensonE.A. LimbilT.L. AllisonB.M. GoeblM.G. HarringtonM.A. Alpha-lipoic acid modulates ovarian surface epithelial cell growth.Gynecol. Oncol.20061031455210.1016/j.ygyno.2006.01.06016574204
    [Google Scholar]
  53. YangY. FangE. LuoJ. WuH. JiangY. LiuY. TongS. WangZ. ZhouR. TongQ. The antioxidant alpha-lipoic acid inhibits proliferation and invasion of human gastric cancer cells via suppression of STAT3-mediated MUC4 gene expression.Oxid. Med. Cell. Longev.2019201911010.1155/2019/364371531915505
    [Google Scholar]
  54. ÇakatayU. KayalıR. SivasA. TekeliF. Prooxidant activities of alpha-lipoic acid on oxidative protein damage in the aging rat heart muscle.Arch. Gerontol. Geriatr.200540323124010.1016/j.archger.2004.09.00115814157
    [Google Scholar]
  55. SuhJ.H. ShigenoE.T. MorrowJ.D. CoxJ.B. RochaA. FreiB. HagenT.M. Oxidative stress in the aging rat heart is reversed by dietary supplementation with ( R )-α-Lipoic acid.FASEB J.200115370070610.1096/fj.00‑0176com11259388
    [Google Scholar]
  56. Di NicuoloF. CastellaniR. TicconiC. ScambiaG. PontecorviA. Di SimoneN. α-Lipoic acid and its role on female reproduction.Curr. Protein Pept. Sci.2021221176777410.2174/138920372266621102910241734719371
    [Google Scholar]
  57. PetcaA. BotM. MaruN. CaloI. BorislavschiA. DumitrascuM. PetcaR.C. SandruF. ZvancaM. Benefits of α-lipoic acid in high-risk pregnancies (Review).Exp. Ther. Med.2021225123210.3892/etm.2021.1066634539828
    [Google Scholar]
  58. GasmiA. NasreenA. LenchykL. LysiukR. PeanaM. ShapovalovaN. PiscopoS. KomissarenkoM. ShanaidaM. SmetaninaK. AntonyakH. FiraL. LykhatskyiP. FiraD. BjørklundG. An update on glutathione’s biosynthesis, metabolism, functions, and medicinal purposes.Curr. Med. Chem.2023315637921175
    [Google Scholar]
  59. ZhangW.J. FreiB. α-Lipoic acid inhibits TNF-a-induced NF-κB activation and adhesion molecule expression in human aortic endothelial cells.FASEB J.200115132423243210.1096/fj.01‑0260com11689467
    [Google Scholar]
  60. DinicolaS. ProiettiS. CucinaA. BizzarriM. FusoA. Alpha-lipoic acid downregulates IL-1β and IL-6 by DNA hypermethylation in SK-N-BE neuroblastoma cells.Antioxidants2017647410.3390/antiox604007428954414
    [Google Scholar]
  61. Badr-EldinS.M. FahmyU.A. AldawsariH.M. AhmedO.A.A. AlhakamyN.A. OkbazghiS.Z. El-MoselhyM.A. AlghaithA.F. AnterA. MatoukA.I. MahdiW.A. AlshehriS. BakhaidarR. Optimized self-nanoemulsifying delivery system based on plant-derived oil augments alpha-lipoic acid protective effects against experimentally induced gastric lesions.Dose Resp.202119110.1177/1559325821100125933867893
    [Google Scholar]
  62. AmomZ. ZakariaZ. MohamedJ. AzlanA. BahariH. Taufik Hidayat BaharuldinM. Aris MoklasM. OsmanK. AsmawiZ. Kamal Nik HassanM. Lipid lowering effect of antioxidant alpha-lipoic acid in experimental atherosclerosis.J. Clin. Biochem. Nutr.2008432889410.3164/jcbn.200805118818758
    [Google Scholar]
  63. MotaM. BaniniB.A. CazanaveS.C. SanyalA.J. Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease.Metabolism20166581049106110.1016/j.metabol.2016.02.01426997538
    [Google Scholar]
  64. MolzP. SchröderN. Potential therapeutic effects of lipoic acid on memory deficits related to aging and neurodegeneration.Front. Pharmacol.2017884910.3389/fphar.2017.0084929311912
    [Google Scholar]
  65. dos SantosS.M. RomeiroC.F.R. RodriguesC.A. CerqueiraA.R.L. MonteiroM.C. Mitochondrial dysfunction and alpha-lipoic acid: Beneficial or harmful in Alzheimer’s disease?Oxid. Med. Cell. Longev.2019201911410.1155/2019/840932931885820
    [Google Scholar]
  66. AkbariE. AsemiZ. Daneshvar KakhakiR. BahmaniF. KouchakiE. TamtajiO.R. HamidiG.A. SalamiM. Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer’s disease: A randomized, double-blind and controlled trial.Front. Aging Neurosci.2016825610.3389/fnagi.2016.0025627891089
    [Google Scholar]
  67. BittnerF. MurchisonC. KoopD. BourdetteD. SpainR. Lipoic acid pharmacokinetics at baseline and 1 year in secondary progressive MS.Neurol. Neuroimmunol. Neuroinflamm.201745e38010.1212/NXI.000000000000038028680918
    [Google Scholar]
  68. ZhangJ. ZhaoY. ZhangY. GaoY. LiS. ChangC. GaoX. ZhaoJ. YangG. Alpha lipoic acid treatment in late middle age improves cognitive function: Proteomic analysis of the protective mechanisms in the hippocampus.Neurosci. Lett.202379813709810.1016/j.neulet.2023.13709836708754
    [Google Scholar]
  69. StaykovH. LazarovaM. HassanovaY. StefanovaM. TanchevaL. NikolovR. Neuromodulatory mechanisms of a memory loss-preventive effect of alpha-lipoic acid in an experimental rat model of dementia.J. Mol. Neurosci.20227251018102510.1007/s12031‑022‑01979‑y35174445
    [Google Scholar]
  70. KhanH. SinghT.G. DahiyaR.S. Abdel-DaimM.M. α-Lipoic acid, an organosulfur biomolecule a novel therapeutic agent for neurodegenerative disorders: An mechanistic perspective.Neurochem. Res.20224771853186410.1007/s11064‑022‑03598‑w35445914
    [Google Scholar]
  71. LovellM.A. MarkesberyW.R. Oxidative damage in mild cognitive impairment and early Alzheimer’s disease.J. Neurosci. Res.200785143036304010.1002/jnr.2134617510979
    [Google Scholar]
  72. MontineT.J. NeelyM.D. QuinnJ.F. BealM.F. MarkesberyW.R. RobertsL.J.II MorrowJ.D. Lipid peroxidation in aging brain and Alzheimer’s disease.Free Radic. Biol. Med.200233562062610.1016/S0891‑5849(02)00807‑912208348
    [Google Scholar]
  73. ChoJ-Y. UmH.S. KangE-B. ChoI.H. KimC.H. ChoJ.S. HwangD.Y. The combination of exercise training and α-Lipoic acid treatment has therapeutic effects on the pathogenic phenotypes of Alzheimer’s disease in NSE/APPsw-transgenic mice.Int. J. Mol. Med.201025333734610.3892/ijmm_0000035020127037
    [Google Scholar]
  74. PeiX. HuF. HuZ. LuoF. LiX. XingS. SunL. LongD. Neuroprotective effect of α-Lipoic acid against Aβ25–35-induced damage in BV2 cells.Molecules2023283116810.3390/molecules2803116836770835
    [Google Scholar]
  75. TaiS. ZhengQ. ZhaiS. CaiT. XuL. YangL. JiaoL. ZhangC. Alpha-lipoic acid mediates clearance of iron accumulation by regulating iron metabolism in a Parkinson’s disease model induced by 6-OHDA.Front. Neurosci.20201461210.3389/fnins.2020.0061232670009
    [Google Scholar]
  76. ZhengQ. MaP. YangP. ZhaiS. HeM. ZhangX. TuQ. JiaoL. YeL. FengZ. ZhangC. Alpha lipoic acid ameliorates motor deficits by inhibiting ferroptosis in Parkinson’s disease.Neurosci. Lett.202381013734610.1016/j.neulet.2023.13734637308056
    [Google Scholar]
  77. MemuduA.E. AdanikeR.P. Alpha lipoic acid reverses scopolamine-induced spatial memory loss and pyramidal cell neurodegeneration in the prefrontal cortex of Wistar rats.IBRO Neurosci. Reports2022131810.1016/j.ibneur.2022.05.00535664083
    [Google Scholar]
  78. CarotaG. DistefanoA. SpampinatoM. GiallongoC. BroggiG. LonghitanoL. PalumboG.A. ParentiR. CaltabianoR. GiallongoS. Di RosaM. PolosaR. BramantiV. VicarioN. Li VoltiG. TibulloD. Neuroprotective role of α-Lipoic acid in iron-overload-mediated toxicity and inflammation in in vitro and in vivo models.Antioxidants2022118159610.3390/antiox1108159636009316
    [Google Scholar]
  79. LiuL. YangS. WangH. α-Lipoic acid alleviates ferroptosis in the MPP + -induced PC12 cells via activating the PI3K/Akt/Nrf2 pathway.Cell Biol. Int.202145242243110.1002/cbin.1150533241887
    [Google Scholar]
  80. ZhangJ. GaoY. ZhangL. ZhangC. ZhaoY. ZhangY. LiS. ChangC. ZhangX. YangG. Alpha-lipoic acid attenuates MPTP/MPP+-induced neurotoxicity: Roles of SIRT1-dependent PGC-1α signaling pathways.Neurotox. Res.202240241041910.1007/s12640‑022‑00479‑635146598
    [Google Scholar]
  81. LvS. HeS. LingX. WangY. HuangC. LongJ. WangJ. QinY. WeiH. YuC.Y. Review of lipoic acid: From a clinical therapeutic agent to various emerging biomaterials.Int. J. Pharm.202262712220110.1016/j.ijpharm.2022.12220136115465
    [Google Scholar]
  82. MantleD. HargreavesI.P. Mitochondrial dysfunction and neurodegenerative disorders: Role of nutritional supplementation.Int. J. Mol. Sci.202223201260310.3390/ijms23201260336293457
    [Google Scholar]
  83. OgawaT. SawaneK. OokoshiK. KawashimaR. Supplementation with flaxseed oil rich in alpha-linolenic acid improves verbal fluency in healthy older adults.Nutrients2023156149910.3390/nu1506149936986229
    [Google Scholar]
  84. BasileG.A. IannuzzoF. XerraF. GenoveseG. PandolfoG. CedroC. MuscatelloM.R.A. BrunoA. Cognitive and mood effect of alpha-lipoic acid supplementation in a nonclinical elder sample: An open-label pilot study.Int. J. Environ. Res. Public Health2023203235810.3390/ijerph2003235836767724
    [Google Scholar]
  85. TriggianiL. Potential therapeutic effects of alpha lipoic acid in memory disorders.Prog. Nutr.20202211219
    [Google Scholar]
  86. LalR. DharavathR.N. ChopraK. Alpha-lipoic acid ameliorates doxorubicin-induced cognitive impairments by modulating neuroinflammation and oxidative stress via NRF-2/HO-1 signaling pathway in the rat hippocampus.Neurochem. Res.20234882476248910.1007/s11064‑023‑03914‑y37017891
    [Google Scholar]
  87. MohseniM. MotallebzadehE. AghighiF. VakiliZ. TalaeiS.A. Neuroprotective effects of alpha-lipoic acid on radiation-induced brainstem injury in rats.Res. Pharm. Sci.202318220220910.4103/1735‑5362.36779836873276
    [Google Scholar]
  88. KoC.Y. XuJ.H. ChangY.W. LoY.M. WuJ.S.B. HuangW.C. ShenS.C. Effects of α-Lipoic acid on phagocytosis of oligomeric beta-amyloid1–42 in BV-2 mouse microglial cells.Front. Aging Neurosci.20221378872310.3389/fnagi.2021.78872335095473
    [Google Scholar]
  89. MaciejczykM. ŻebrowskaE. NesterowiczM. Żendzian-PiotrowskaM. ZalewskaA. α-Lipoic acid strengthens the antioxidant barrier and reduces oxidative, nitrosative, and glycative damage, as well as inhibits inflammation and apoptosis in the hypothalamus but not in the cerebral cortex of insulin-resistant rats.Oxid. Med. Cell. Longev.2022202212110.1155/2022/745051435391928
    [Google Scholar]
  90. de FreitasR.M. Lipoic Acid increases hippocampal choline acetyltransferase and acetylcholinesterase activities and improvement memory in epileptic rats.Neurochem. Res.201035116217010.1007/s11064‑009‑0041‑619669875
    [Google Scholar]
  91. VianaM.D.M. LauriaP.S.S. LimaA.A. OpretzkaL.C.F. MarcelinoH.R. VillarrealC.F. Alpha-lipoic acid as an antioxidant strategy for managing neuropathic pain.Antioxidants20221112242010.3390/antiox1112242036552628
    [Google Scholar]
  92. RodriguesP. CassanegoG.B. PeresD.S. VieroF.T. KudsiS.Q. RuviaroN.A. AiresK.V. PortelaV.M. BauermannL.D.F. TrevisanG. Alpha-lipoic acid reduces nociception by reducing oxidative stress and neuroinflammation in a model of complex regional pain syndrome type I in mice.Behav. Brain Res.202445911479010.1016/j.bbr.2023.11479038040057
    [Google Scholar]
  93. RahimlouM. AsadiM. Banaei JahromiN. MansooriA. Alpha-lipoic acid (ALA) supplementation effect on glycemic and inflammatory biomarkers: A Systematic Review and meta-analysis.Clin. Nutr. ESPEN201932162810.1016/j.clnesp.2019.03.01531221283
    [Google Scholar]
  94. CollottaD. FranchinaM.P. CarlucciV. CollinoM. Recent advances in JAK inhibitors for the treatment of metabolic syndrome.Front. Pharmacol.202314124553510.3389/fphar.2023.124553537701031
    [Google Scholar]
  95. Della TorreS. Non-alcoholic fatty liver disease as a canonical example of metabolic inflammatory-based liver disease showing a sex-specific prevalence: Relevance of estrogen signaling.Front. Endocrinol. (Lausanne)20201157249010.3389/fendo.2020.57249033071979
    [Google Scholar]
  96. HoC.M. HoS.L. JengY.M. LaiY.S. ChenY.H. LuS.C. ChenH.L. ChangP.Y. HuR.H. LeeP.H. Accumulation of free cholesterol and oxidized low-density lipoprotein is associated with portal inflammation and fibrosis in nonalcoholic fatty liver disease.J. Inflamm. (Lond.)2019161710.1186/s12950‑019‑0211‑530983887
    [Google Scholar]
  97. TianS. NakamuraJ. HillerS. SimingtonS. HolleyD.W. MotaR. WillisM.S. BultmanS.J. LuftJ.C. DeSimoneJ.M. JiaZ. MaedaN. YiX. New insights into immunomodulation via overexpressing lipoic acid synthase as a therapeutic potential to reduce atherosclerosis.Vascul. Pharmacol.2020133-13410677710.1016/j.vph.2020.10677732750408
    [Google Scholar]
  98. BaziarN. Nasli-EsfahaniE. DjafarianK. QorbaniM. HedayatiM. MishaniM.A. FaghfooriZ. AhmaripourN. HosseiniS. The beneficial effects of alpha lipoic acid supplementation on Lp-PLA2 mass and its distribution between HDL and apoB-containing lipoproteins in type 2 diabetic patients: A randomized, double-blind, placebo-controlled trial.Oxid. Med. Cell. Longev.2020202011310.1155/2020/585086532256955
    [Google Scholar]
  99. EvansJ.D. HeatonR.K. PaulsenJ.S. PalmerB.W. PattersonT. JesteD.V. The relationship of neuropsychological abilities to specific domains of functional capacity in older schizophrenia patients.Biol. Psychiatry200353542243010.1016/S0006‑3223(02)01476‑212614995
    [Google Scholar]
  100. AkbariM. OstadmohammadiV. TabriziR. MobiniM. LankaraniK.B. MoosazadehM. HeydariS.T. ChamaniM. KolahdoozF. AsemiZ. The effects of alpha-lipoic acid supplementation on inflammatory markers among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled trials.Nutr. Metab. (Lond.)20181513910.1186/s12986‑018‑0274‑y29930690
    [Google Scholar]
  101. EricksonN. ZafronM. HardingS.V. MarinangeliC.P.F. RideoutT.C. Evaluating the lipid-lowering effects of α-Lipoic acid supplementation: A systematic review.J. Diet. Suppl.202017675376710.1080/19390211.2019.165143631416362
    [Google Scholar]
  102. CapeceU. MoffaS. ImprotaI. Di GiuseppeG. NistaE.C. CefaloC.M.A. CintiF. PontecorviA. GasbarriniA. GiaccariA. MezzaT. Alpha-Lipoic acid and glucose metabolism: A comprehensive update on biochemical and therapeutic features.Nutrients20221511810.3390/nu1501001836615676
    [Google Scholar]
  103. LeeW.J. SongK.H. KohE.H. WonJ.C. KimH.S. ParkH.S. KimM.S. KimS.W. LeeK.U. ParkJ.Y. α-Lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle.Biochem. Biophys. Res. Commun.2005332388589110.1016/j.bbrc.2005.05.03515913551
    [Google Scholar]
  104. GhelaniH. Razmovski-NaumovskiV. NammiS. Chronic treatment of (R)- α -lipoic acid reduces blood glucose and lipid levels in high-fat diet and low-dose streptozotocin-induced metabolic syndrome and type 2 diabetes in Sprague-Dawley rats.Pharmacol. Res. Perspect.201753e0030610.1002/prp2.30628603627
    [Google Scholar]
  105. YangY. LiW. LiuY. LiY. GaoL. ZhaoJ. Alpha-lipoic acid attenuates insulin resistance and improves glucose metabolism in high fat diet-fed mice.Acta Pharmacol. Sin.201435101285129210.1038/aps.2014.6425152027
    [Google Scholar]
  106. AnthonyR.M. MacLeayJ.M. GrossK.L. Alpha-Lipoic acid as a nutritive supplement for humans and animals: An overview of its use in dog food.Animals (Basel)2021115145410.3390/ani1105145434069383
    [Google Scholar]
  107. DerkarabetianS. SteinmannD.B. HedinM. Repeated and time-correlated morphological convergence in cave-dwelling harvestmen (Opiliones, Laniatores) from Montane Western North America.PLoS One201055e1038810.1371/journal.pone.001038820479884
    [Google Scholar]
  108. HahmJ.R. NohH.S. HaJ.H. RohG.S. KimD.R. Alpha-lipoic acid attenuates adipocyte differentiation and lipid accumulation in 3T3-L1 cells via AMPK-dependent autophagy.Life Sci.2014100212513210.1016/j.lfs.2014.02.00124530288
    [Google Scholar]
  109. Fernández-GalileaM. Pérez-MatuteP. Prieto-HontoriaP.L. MartinezJ.A. Moreno-AliagaM.J. Effects of lipoic acid on lipolysis in 3T3-L1 adipocytes.J. Lipid Res.201253112296230610.1194/jlr.M02708622941773
    [Google Scholar]
  110. HouX. XuS. Maitland-ToolanK.A. SatoK. JiangB. IdoY. LanF. WalshK. WierzbickiM. VerbeurenT.J. CohenR.A. ZangM. SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase.J. Biol. Chem.200828329200152002610.1074/jbc.M80218720018482975
    [Google Scholar]
  111. KuoY.T. LinT.H. ChenW.L. LeeH.M. Alpha-lipoic acid induces adipose triglyceride lipase expression and decreases intracellular lipid accumulation in HepG2 cells.Eur. J. Pharmacol.20126921-3101810.1016/j.ejphar.2012.07.02822819708
    [Google Scholar]
  112. ChengL.C. SuK.H. KouY.R. ShyueS.K. ChingL.C. YuY.B. WuY.L. PanC.C. LeeT.S. α-Lipoic acid ameliorates foam cell formation via liver X receptor α-dependent upregulation of ATP-binding cassette transporters A1 and G1.Free Radic. Biol. Med.2011501475410.1016/j.freeradbiomed.2010.10.70621034810
    [Google Scholar]
  113. LiW. YinL. SunX. WuJ. DongZ. HuK. SunA. GeJ. Alpha-lipoic acid protects against pressure overload-induced heart failure via ALDH2-dependent Nrf1- FUNDC1 signaling.Cell Death Dis.202011759910.1038/s41419‑020‑02805‑232732978
    [Google Scholar]
  114. LeeW.R. KimA. KimK.S. ParkY.Y. ParkJ.H. KimK.H. KimS.J. ParkK.K. Alpha-lipoic acid attenuates atherosclerotic lesions and inhibits proliferation of vascular smooth muscle cells through targeting of the Ras/MEK/ERK signaling pathway.Mol. Biol. Rep.20123966857686610.1007/s11033‑012‑1511‑522302393
    [Google Scholar]
  115. AhmadiM. KeshavarzS.A. AbbasiB. Effects of alpha lipoic acid supplementation on serum lipid profile in patients with metabolic syndrome: A randomized, double-blind, placebo-controlled clinical trial.ARYA Atheroscler.20221841836817351
    [Google Scholar]
  116. ManningP.J. SutherlandW.H.F. WilliamsS.M. WalkerR.J. BerryE.A. De JongS.A. RyallsA.R. The effect of lipoic acid and vitamin E therapies in individuals with the metabolic syndrome.Nutr. Metab. Cardiovasc. Dis.201323654354910.1016/j.numecd.2011.11.00622402059
    [Google Scholar]
  117. JiangY. JinM. ChenJ. YanJ. LiuP. YaoM. CaiW. PiR. Discovery of a novel niacin-lipoic acid dimer N2L attenuating atherosclerosis and dyslipidemia with non-flushing effects.Eur. J. Pharmacol.202086817287110.1016/j.ejphar.2019.17287131846627
    [Google Scholar]
  118. XihuaL. LiH. Obesity: Epidemiology, pathophysiology, and therapeutics.Front. Endocrinol.202112p. 706978
    [Google Scholar]
  119. YounossiZ. AnsteeQ.M. MariettiM. HardyT. HenryL. EslamM. GeorgeJ. BugianesiE. Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention.Nat. Rev. Gastroenterol. Hepatol.2018151112010.1038/nrgastro.2017.10928930295
    [Google Scholar]
  120. KhanA. RossH.M. ParraN.S. ChenS.L. ChauhanK. WangM. YanB. MagagnaJ. BeirigerJ. ShahY. ShahzadT. Halegoua-DeMarzioD. Risk prevention and health promotion for non-alcoholic fatty liver diseases (NAFLD).Livers20222426428210.3390/livers2040022
    [Google Scholar]
  121. ChoK.J. MoonH.E. MoiniH. PackerL. YoonD.Y. ChungA.S. Alpha-lipoic acid inhibits adipocyte differentiation by regulating pro-adipogenic transcription factors via mitogen-activated protein kinase pathways.J. Biol. Chem.200327837348233483310.1074/jbc.M21074720012837769
    [Google Scholar]
  122. HillerS. DeKroonR. HamlettE.D. XuL. OsorioC. RobinetteJ. WinnikW. SimingtonS. MaedaN. AlzateO. YiX. Alpha-lipoic acid supplementation protects enzymes from damage by nitrosative and oxidative stress.Biochim. Biophys. Acta, Gen. Subj.2016186011PtA364510.1016/j.bbagen.2015.09.00126344063
    [Google Scholar]
  123. ZhaoL. HuF.X. α-Lipoic acid treatment of aged type 2 diabetes mellitus complicated with acute cerebral infarction.Eur. Rev. Med. Pharmacol. Sci.201418233715371925535146
    [Google Scholar]
  124. McNeillyA.M. DavisonG.W. MurphyM.H. NadeemN. TrinickT. DulyE. NovialsA. McEnenyJ. Effect of α-Lipoic acid and exercise training on cardiovascular disease risk in obesity with impaired glucose tolerance.Lipids Health Dis.20111011910.1186/1476‑511X‑10‑21722107734
    [Google Scholar]
  125. PassiatoreM. PernaA. TaccardoG. CilliV. ProiettiL. De VitisR. Pharmacological management of mild- moderate carpal tunnel syndrome: Use of Crocus sativus L. combined with alpha-lipoic acid.J. Xiangya Med.20227310.21037/jxym‑21‑48
    [Google Scholar]
  126. RezaeiS. SasaniM.R. AkhlaghiM. KohanmooA. Flaxseed oil in the context of a weight loss programme ameliorates fatty liver grade in patients with non-alcoholic fatty liver disease: A randomised double-blind controlled trial.Br. J. Nutr.20201239994100210.1017/S000711452000031831992372
    [Google Scholar]
  127. Al ShafeiO.S. ElbagoryS.W. Journal of Home Economics, Menoufia University.Shibin El Kom, Egypt20213141300
    [Google Scholar]
  128. MoonH.S. Chemopreventive effects of alpha lipoic acid on obesity-related cancers.Ann. Nutr. Metab.201668213714410.1159/00044399426829711
    [Google Scholar]
  129. EbadaM.A. FayedN. FayedL. AlkanjS. AbdelkarimA. FarwatiH. HanafyA. NegidaA. EbadaM. NoserY. Efficacy of alpha-lipoic acid in the management of diabetes mellitus: A systematic review and meta-analysis.Iran. J. Pharm. Res.20191842144215632184879
    [Google Scholar]
  130. DeshpandeA.D. Harris-HayesM. SchootmanM. Epidemiology of diabetes and diabetes-related complications.Phys. Ther.200888111254126410.2522/ptj.2008002018801858
    [Google Scholar]
  131. El hussenyM.W.A. MamdouhM. ShabanS. Ibrahim AbushoukA. ZakiM.M.M. AhmedO.M. Abdel-DaimM.M. Adipokines: Potential therapeutic targets for vascular dysfunction in type ii diabetes mellitus and obesity.J. Diabetes Res.201711110.1155/2017/809592628286779
    [Google Scholar]
  132. HegazyS.K. TolbaO.A. MostafaT.M. EidM.A. El-AfifyD.R. Alpha-lipoic acid improves subclinical left ventricular dysfunction in asymptomatic patients with type 1 diabetes.Rev. Diabet. Stud.2013101586710.1900/RDS.2013.10.5824172699
    [Google Scholar]
  133. SenaC.M. NunesE. LouroT. ProençaT. FernandesR. BoarderM.R. SeiçaR.M. Effects of α-Lipoic acid on endothelial function in aged diabetic and high-fat fed rats.Br. J. Pharmacol.2008153589490610.1038/sj.bjp.070747417906683
    [Google Scholar]
  134. BashanN. KovsanJ. KachkoI. OvadiaH. RudichA. Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species.Physiol. Rev.2009891277110.1152/physrev.00014.200819126754
    [Google Scholar]
  135. GolbidiS. BadranM. LaherI. Diabetes and alpha lipoic acid.Front. Pharmacol.201126910.3389/fphar.2011.0006922125537
    [Google Scholar]
  136. ZieglerD. AmetovA. BarinovA. DyckP.J. GurievaI. LowP.A. MunzelU. YakhnoN. RazI. NovosadovaM. MausJ. SamigullinR. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: The SYDNEY 2 trial.Diabetes Care200629112365237010.2337/dc06‑121617065669
    [Google Scholar]
  137. KamenovaP. Improvement of insulin sensitivity in patients with type 2 diabetes mellitus after oral administration of alpha-lipoic acid.Hormones (Athens)20065425125810.14310/horm.2002.1119117178700
    [Google Scholar]
  138. PalackaP. KucharskaJ. MurinJ. DostalovaK. OkkelovaA. CizovaM. WaczulikovaI. MoricovaS. GvozdjakovaA. Complementary therapy in diabetic patients with chronic complications: A pilot study.Bratisl. Lek Listy2010111420521120586147
    [Google Scholar]
  139. GholamiS. MokhtariB. BadalzadehR. Alpha-lipoic acid potentiates the anti-arrhythmic effects of ischemic postconditioning in the setting of cardiac ischemia/reperfusion injury in diabetic rats.J. Diabetes Metab. Disord.202221170771610.1007/s40200‑022‑01034‑y35673476
    [Google Scholar]
  140. TasciI. DemirC. KulogluT. Effects of alpha lipoic acid on loss of myelin sheath of sciatic nerve in experimentally induced diabetic rats.Med. Arh.201872317818110.5455/medarh.2018.72.178‑18130061762
    [Google Scholar]
  141. HsiehR.Y. HuangI.C. ChenC. SungJ.Y. Effects of oral alpha-lipoic acid treatment on diabetic polyneuropathy: A meta-analysis and systematic review.Nutrients20231516363410.3390/nu1516363437630823
    [Google Scholar]
  142. MačákováD. Association of oxidative stress markers with vascular stiffness parameters in patients with diabetic neuropathy.J. Biomed. (Syd.)202221112
    [Google Scholar]
  143. BjørklundG. Cruz-MartinsN. GohB.H. MykhailenkoO. LysiukR. ShanaidaM. LenchykL. UpyrT. RusuM.E. PryshlyakA. ShanaidaV. ChirumboloS. Medicinal plant-derived phytochemicals in detoxification.Curr. Pharm. Des.2023299424210.2174/138161282966623080909424237559241
    [Google Scholar]
  144. GuL. LiS. BaiJ. ZhangQ. HanZ. α-Lipoic acid protects against microcystin-LR induced hepatotoxicity through regeneration of glutathione via activation of Nrf2.Environ. Toxicol.202035773874610.1002/tox.2290832061150
    [Google Scholar]
  145. XuW. WangL. NiuY. MaoL. DuX. ZhangP. LiZ. LiH. LiN. A review of edible plant-derived natural compounds for the therapy of liver fibrosis.Eur. J. Gastroenterol. Hepatol.202335213315210.1097/MEG.000000000000248336574304
    [Google Scholar]
  146. GasmiA. Gasmi BenahmedA. ShanaidaM. ChirumboloS. MenzelA. AnzarW. ArshadM. Cruz-MartinsN. LysiukR. BeleyN. OliinykP. ShanaidaV. DenysA. PeanaM. BjørklundG. Anticancer activity of broccoli, its organosulfur and polyphenolic compounds.Crit. Rev. Food Sci. Nutr.2023111910.1080/10408398.2023.219549337129118
    [Google Scholar]
  147. El-MancyE.M. ElsherbiniD.M.A. Al-SerwiR.H. El-SherbinyM. Ahmed ShakerG. Abdel-MoneimA.M.H. EnanE.T. ElsherbinyN.M. α-Lipoic acid Protects against cyclosporine a-induced hepatic toxicity in rats: Effect on oxidative stress, inflammation, and apoptosis.Toxics202210844210.3390/toxics1008044236006121
    [Google Scholar]
  148. Galicia-MorenoM. Rosique-OramasD. Medina-AvilaZ. Álvarez-TorresT. FalcónD. Higuera-de la tijeraF. BéjarY.L. Cordero-PérezP. Muñoz-EspinosaL. Pérez-HernándezJ.L. KershenobichD. Gutierrez-ReyesG. Behavior of oxidative stress markers in alcoholic liver cirrhosis patients.Oxid. Med. Cell. Longev.2016201611010.1155/2016/937056528074118
    [Google Scholar]
  149. LiuG. LiuJ. PianL. GuiS. LuB. α-lipoic acid protects against carbon tetrachloride-induced liver cirrhosis through the suppression of the TGF-β/Smad3 pathway and autophagy.Mol. Med. Rep.201820181910.3892/mmr.2018.971930535447
    [Google Scholar]
  150. SenaC. CiprianoM. BotelhoM. SeiçaR. Lipoic Acid prevents high-fat diet-induced hepatic steatosis in Goto Kakizaki rats by reducing oxidative stress through Nrf2 activation.Int. J. Mol. Sci.2018199270610.3390/ijms1909270630208622
    [Google Scholar]
  151. WenzelP. HinkU. OelzeM. SchuppanS. SchaeubleK. SchildknechtS. HoK.K. WeinerH. BachschmidM. MünzelT. DaiberA. Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde dehydrogenase (ALDH-2) activity. Implications for mitochondrial oxidative stress and nitrate tolerance.J. Biol. Chem.2007282179279910.1074/jbc.M60647720017102135
    [Google Scholar]
  152. PatrickL. Mercury toxicity and antioxidants: Part 1: role of glutathione and alpha-lipoic acid in the treatment of mercury toxicity.Altern. Med. Rev.20027645647112495372
    [Google Scholar]
  153. LiebeR. EspositoI. BockH.H. vom DahlS. StindtJ. BaumannU. LueddeT. KeitelV. Diagnosis and management of secondary causes of steatohepatitis.J. Hepatol.20217461455147110.1016/j.jhep.2021.01.04533577920
    [Google Scholar]
  154. BaiJ. ChenC. SunY. LiS. HeR. ZhangQ. SunQ. HuangY. TanA. YuanL. HuangY. LanY. HanZ. α-LA attenuates microcystin-LR-induced hepatocellular oxidative stress in mice through Nrf2-mediated antioxidant and detoxifying enzymes.Toxicon202323510731310.1016/j.toxicon.2023.10731337832850
    [Google Scholar]
  155. MohammedM.A. GharibD.M. ReyadH.R. MohamedA.A. ElrobyF.A. MahmoudH.S. Antioxidant and anti-inflammatory properties of alpha-lipoic acid protect against valproic acid-induced liver injury.Can. J. Physiol. Pharmacol.202199549950510.1139/cjpp‑2019‑045633275538
    [Google Scholar]
  156. ZhaoY. LiuX. LiangC. PeiT. GuoM. WangJ. ZhangJ. α-Lipoic acid alleviated fluoride-induced hepatocyte injury via inhibiting ferroptosis.J. Agric. Food Chem.20227050159621597110.1021/acs.jafc.2c0748436459405
    [Google Scholar]
  157. KhalafA.A. ZakiA.R. GalalM.K. OgalyH.A. IbrahimM.A. HassanA. The potential protective effect of α-Lipoic acid against nanocopper particle–induced hepatotoxicity in male rats.Hum. Exp. Toxicol.201736988189110.1177/096032711667452627827802
    [Google Scholar]
  158. SadekK.M. SalehE.A. NasrS.M. Molecular hepatoprotective effects of lipoic acid against carbon tetrachloride-induced liver fibrosis in rats.Hum. Exp. Toxicol.201837214215410.1177/096032711769306629233029
    [Google Scholar]
  159. GezerA. LalogluA. Kirli BölükbaşM. Protective effects of alpha lipoic acid against ionizing radiation- induced hepatotoxicity in rats.Eurasian J. Med.202355210410837403907
    [Google Scholar]
  160. KoC.Y. LoY.M. XuJ.H. ChangW.C. HuangD.W. WuJ.S.B. YangC.H. HuangW.C. ShenS.C. Alpha-lipoic acid alleviates NAFLD and triglyceride accumulation in liver modulating hepatic NLRP3 inflammasome activation pathway in type 2 diabetic rats.Food Sci. Nutr.2021952733274210.1002/fsn3.223534026086
    [Google Scholar]
  161. AttiaM. EssaE.A. ZakiR.M. ElkordyA.A. An overview of the antioxidant effects of ascorbic acid and alpha lipoic acid (in liposomal forms) as adjuvant in cancer treatment.Antioxidants20209535910.3390/antiox905035932344912
    [Google Scholar]
  162. LeeH.S. NaM.H. KimW.K. α-Lipoic acid reduces matrix metalloproteinase activity in MDA-MB-231 human breast cancer cells.Nutr. Res.201030640340910.1016/j.nutres.2010.06.00920650348
    [Google Scholar]
  163. FahmyU.A. AljaeidB.M. Combined strategy for suppressing breast carcinoma MCF-7 cell lines by loading simvastatin on alpha lipoic acid nanoparticles.Expert Opin. Drug Deliv.201613121653166010.1080/17425247.2016.123678827636370
    [Google Scholar]
  164. PuchsakaP. ChaothamC. ChanvorachoteP. α-Lipoic acid sensitizes lung cancer cells to chemotherapeutic agents and anoikis via integrin β1/β3 downregulation.Int. J. Oncol.20164941445145610.3892/ijo.2016.362427431988
    [Google Scholar]
  165. JeonM.J. KimW.G. LimS. ChoiH.J. SimS. KimT.Y. ShongY.K. KimW.B. Alpha lipoic acid inhibits proliferation and epithelial mesenchymal transition of thyroid cancer cells.Mol. Cell. Endocrinol.201641911312310.1016/j.mce.2015.10.00526463583
    [Google Scholar]
  166. Kuban-JankowskaA. Gorska-PonikowskaM. WozniakM. Lipoic acid decreases the viability of breast cancer cells and activity of PTP1B and SHP2.Anticancer Res.20173762893289828551626
    [Google Scholar]
  167. LiouG.Y. StorzP. Reactive oxygen species in cancer.Free Radic. Res.201044547949610.3109/1071576100366755420370557
    [Google Scholar]
  168. StorzP. Reactive oxygen species in tumor progression.Front. Biosci.2005101-31881189610.2741/166715769673
    [Google Scholar]
  169. TaherianS. KhayamabedR. TavalaeeM. Nasr-EsfahaniM.H. Alpha-lipoic acid minimises reactive oxygen species-induced damages during sperm processing.Andrologia2019518e1331410.1111/and.1331431140635
    [Google Scholar]
  170. PeiY. LiuY.Y. SunM. ZhengJ. ZhouT.T. WangB. HuH. WangZ.L. Beneficial effects of pioglitazone and α-Lipoic acid in patients with polycystic ovaries syndrome.Eur. Rev. Med. Pharmacol. Sci.202327157118712637606122
    [Google Scholar]
  171. Abu-ZaidA. BaradwanS. BukhariI.A. AlyousefA. AbuzaidM. SalehS.A.K. AdlyH.M. AlomarO. Al-BadawiI.A. The effect of alpha-lipoic acid supplementation on anthropometric, glycemic, lipid, oxidative stress, and hormonal parameters in individuals with polycystic ovary syndrome: A systematic review and meta-analysis of randomized clinical trials.Obstet. Gynecol. Sci.202338044616
    [Google Scholar]
  172. NeitzelC. SeiwertN. GöderA. DiehlE. WeberC. NagelG. StrohS. RasenbergerB. ChristmannM. FahrerJ. Lipoic acid synergizes with antineoplastic drugs in colorectal cancer by targeting p53 for proteasomal degradation.Cells20198879410.3390/cells808079431366086
    [Google Scholar]
  173. FeuereckerB. PirsigS. SeidlC. AichlerM. FeuchtingerA. BrucheltG. Senekowitsch-SchmidtkeR. Lipoic acid inhibits cell proliferation of tumor cells in vitro and in vivo.Cancer Biol. Ther.201213141425143510.4161/cbt.2200322954700
    [Google Scholar]
  174. DongL. YangF. LiJ. LiY. YuX. ZhangX. Effect of oral alpha-lipoic acid (ALA) on sperm parameters: A systematic review and meta-analysis.Basic Clin. Androl.20223212310.1186/s12610‑022‑00173‑936476425
    [Google Scholar]
  175. Di TucciC. GalatiG. MatteiG. BonanniV. CapriO. D’AmelioR. MuziiL. Benedetti PaniciP. The role of alpha lipoic acid in female and male infertility: A systematic review.Gynecol. Endocrinol.202137649750510.1080/09513590.2020.184361933345661
    [Google Scholar]
  176. KaltsasA. Oxidative stress and male infertility: The protective role of antioxidants.Medicina (Kaunas)20235910176910.3390/medicina5910176937893487
    [Google Scholar]
  177. HabibiM. AbbasiB. Fakhari ZavarehZ. EsmaeiliV. ShaverdiA. Sadighi GilaniM.A. TavalaeeM. Nasr EsfahaniM.H. Alpha-lipoic acid ameliorates sperm dna damage and chromatin integrity in men with high DNA damage: A triple blind randomized clinical trial.Cell J.2022241060361136259478
    [Google Scholar]
  178. HabibiM. Fakhari ZavarehZ. AbbasiB. EsmaeiliV. ShahverdiA. Sadighi GilaniM.A. TavalaeeM. Nasr-EsfahaniM.H. Alpha-lipoic acid supplementation for male partner of couples with recurrent pregnancy loss: A post hoc analysis in clinical trial.Int. J. Fertil. Steril.2023171677436617206
    [Google Scholar]
  179. ShayganniaE. Ghandehari-AlavijehR. TavalaeeM. Nasr-EsfahaniM.H. The protective effects of alpha lipoic acid on human sperm function during freezing-thawing.Cryo Lett.202041634435033990811
    [Google Scholar]
  180. NovielliC. AnelliG.M. LissoF. MarzoratiA. ParrillaB. OnetaM. SavasiV.M. CetinI. MandòC. Effects of α-Lipoic acid and myo-inositol supplementation on the oocyte environment of infertile obese women: A preliminary study.Reprod. Biol.202020454154610.1016/j.repbio.2020.10.00233371944
    [Google Scholar]
  181. ÖzelF. KirayM. GökerA. AydemirS. MıcılıS.C. Protective effect of alpha lipoic acid on 4-vinylcyclohexene diepoxide induced primary ovarian failure in female rats.Taiwan. J. Obstet. Gynecol.202059229330010.1016/j.tjog.2020.01.02032127153
    [Google Scholar]
  182. NairD.V. RaniM.U. ReddyA.G. KumarB.K. ReddyM.A. LakshmanM. RajkumarU. Protective effect of alpha-lipoic acid and omega-3 fatty acids against cyclophosphamide-induced ovarian toxicity in rats.Vet. World202013118819610.14202/vetworld.2020.188‑19632158171
    [Google Scholar]
  183. SaidR.S. MohamedH.A. KassemD.H. Alpha-lipoic acid effectively attenuates ionizing radiation-mediated testicular dysfunction in rats: Crosstalk of NF-ĸB, TGF-β, and PPAR-ϒ pathways.Toxicology202044215253610.1016/j.tox.2020.15253632649955
    [Google Scholar]
  184. NaderiN. DarmishonnejadZ. TavalaeeM. Nasr-EsfahaniM.H. The effect of alpha-lipoic acid on sperm functions in rodent models for male infertility: A systematic review.Life Sci.202332312138310.1016/j.lfs.2023.12138336640903
    [Google Scholar]
  185. AbbasiB. MolaviN. TavalaeeM. AbbasiH. Nasr-EsfahaniM.H. Alpha-lipoic acid improves sperm motility in infertile men after varicocelectomy: A triple-blind randomized controlled trial.Reprod. Biomed. Online20204161084109110.1016/j.rbmo.2020.08.01333032908
    [Google Scholar]
  186. HodeebY.M. El-RewinyE.M. GaafarA.M. ZayedA.N. HasanM.S. ElsaieM.L. The effect of alpha lipoic acid supplementation on sperm functions in idiopathic asthenozoospermic patients: A case-controlled study.Hum. Fertil. (Camb.)202220221935023797
    [Google Scholar]
  187. JannatifarR. AsaE. SahraeiS.S. VerdiA. PiroozmaneshH. N-acetyl-l-cysteine and alpha lipoic acid are protective supplement on human sperm parameters in cryopreservation of asthenoteratozoospermia patients.Andrologia20225411e1461210.1111/and.1461236321244
    [Google Scholar]
  188. JannatifarR. PiroozmaneshH. SahraeiS.S. AsaE. Combination of alpha lipoic acid and metformin supplement improve assisted reproductive technologies outcomes in polycystic ovary syndrome patients.Anat. Cell Biol.202255223924610.5115/acb.21.24235501295
    [Google Scholar]
  189. FanQ. ChangF.J. XueJ.G. HanZ.Y. SunZ.X. ChenY. Efficacy of Jujing Decoction combined with lipoic acid in the treatment of asthenospermia and teratospermia.Zhonghua Nan Ke Xue202228215716137462489
    [Google Scholar]
  190. AsaE. AhmadiR. MahmoodiM. MohammadniyaA. Supplementation of freezing media with alpha lipoic acid preserves the structural and functional characteristics of sperm against cryodamage in infertile men with asthenoteratozoospermia.Cryobiology20209616617410.1016/j.cryobiol.2020.07.00132652098
    [Google Scholar]
  191. KongD. ChoH. HwangS. ChoiE. LeeA. ChoiE.K. KimY.B. KimH.J. HongS. Bioinformatics and integrated pharmacology network to identify the therapeutic targets and potential molecular mechanism of alpha-lipoic acid on primary ovarian insufficiency.J. Cell. Biochem.2023124101557157210.1002/jcb.3046437660319
    [Google Scholar]
  192. KamtS.F. LiuJ. YanL.J. Renal-protective roles of lipoic acid in kidney disease.Nutrients2023157173210.3390/nu1507173237049574
    [Google Scholar]
  193. SkibskaB. KochanE. StanczakA. LipertA. SkibskaA. Antioxidant and anti-inflammatory effects of α-Lipoic Acid on lipopolysaccharide-induced oxidative stress in rat kidney.Arch. Immunol. Ther. Exp. (Warsz.)20237111610.1007/s00005‑023‑00682‑z37378741
    [Google Scholar]
  194. MirjaliliM. MirzaeiE. VazinA. Pharmacological agents for the prevention of colistin-induced nephrotoxicity.Eur. J. Med. Res.20222716410.1186/s40001‑022‑00689‑w35525994
    [Google Scholar]
  195. Gerardo Yanowsky-EscatellF. Andrade-SierraJ. Pazarín-VillaseñorL. Santana-ArciniegaC. De Jesús Torres-VázquezE. Samuel Chávez-IñiguezJ. Ángel Zambrano-VelardeM. Martín Preciado-FigueroaF. The role of dietary antioxidants on oxidative stress in diabetic nephropathy.Iran. J. Kidney Dis.2020142819432165592
    [Google Scholar]
  196. AbuyassinB. BadranM. AyasN.T. LaherI. The antioxidant α-Lipoic acid attenuates intermittent hypoxia-related renal injury in a mouse model of sleep apnea.Sleep2019426zsz06610.1093/sleep/zsz06630880336
    [Google Scholar]
  197. CavdarZ. OktanM.A. UralC. CalisirM. KocakA. HeybeliC. YildizS. AriciA. EllidokuzH. CelikA. YilmazO. SariogluS. CavdarC. Renoprotective effects of alpha lipoic acid on iron overload-induced kidney injury in rats by suppressing NADPH oxidase 4 and p38 MAPK signaling.Biol. Trace Elem. Res.2020193248349310.1007/s12011‑019‑01733‑331025242
    [Google Scholar]
  198. CavdarZ. OktanM.A. UralC. KocakA. CalisirM. HeybeliC. YildizS. OzbalS. ArslanS. ErgurB.U. YilmazO. CavdarC. Alpha lipoic acid attenuates iron induced oxidative acute kidney injury in rats.Biotech. Histochem.202196640941710.1080/10520295.2020.181200132921159
    [Google Scholar]
  199. Kayhan KuştepeE. BaharL. ZaymanE. SucuN. GülS. GülM. A light microscopic investigation of the renoprotective effects of α-Lipoic acid and α-tocopherol in an experimental diabetic rat model.Biotech. Histochem.202095430531610.1080/10520295.2019.169594232013590
    [Google Scholar]
  200. Rahimi AnbarkehF. NikraveshM.R. JalaliM. SoukhtanlooM. The protective role of alpha-lipoic acid on the appearance of fibronectin and laminin in renal tubules following diazinon exposure: An experimental immunohistochemical study.Toxicology202044415258310.1016/j.tox.2020.15258332911022
    [Google Scholar]
  201. DugbarteyG. AlornyoK. Deborah EwoenamD. AdamsI. Activation of renal CSE/H2S pathway by alpha-lipoic acid protects against histological and functional changes in the diabetic kidney.Biomed Pharmacother.2022153113386
    [Google Scholar]
  202. DugbarteyG.J. AlornyoK.K. N’guessanB.B. AtuleS. MensahS.D. AdjeiS. Supplementation of conventional anti-diabetic therapy with alpha-lipoic acid prevents early development and progression of diabetic nephropathy.Biomed. Pharmacother.202214911281810.1016/j.biopha.2022.11281835286963
    [Google Scholar]
  203. OktanM.A. HeybeliC. UralC. KoçakA. BiliciG. CavdarZ. OzbalS. ArslanS. YilmazO. CavdarC. Alpha-lipoic acid alleviates colistin nephrotoxicity in rats.Hum. Exp. Toxicol.202140576177110.1177/096032712096604333111558
    [Google Scholar]
  204. LaiS. PetramalaL. MuscaritoliM. CianciR. MazzaferroS. MitterhoferA.P. PasqualiM. D’AmbrosioV. CartaM. AnsuiniM. RamacciniC. GalaniA. AmabileM.I. MolfinoA. LetiziaC. α-Lipoic acid in patients with autosomal dominant polycystic kidney disease.Nutrition20207111059410.1016/j.nut.2019.11059431790890
    [Google Scholar]
  205. CilO. PerwadF. α-Lipoic Acid (ALA) improves cystine solubility in Cystinuria: Report of 2 cases.Pediatrics20201455e2019295110.1542/peds.2019‑295132245805
    [Google Scholar]
  206. VakaliE. RigopoulosD. CarrilloA.E. FlourisA.D. DinasP.C. Effects of alpha-lipoic acid supplementation on human diabetic nephropathy: A systematic review and meta-analysis.Curr. Diabetes Rev.2022186e14092119645710.2174/157339981766621091410332934521329
    [Google Scholar]
  207. JiangZ. TanZ. MengF. LiX. Curative effects of valsartan alone or combined with alpha-lipoic acid on inflammatory cytokines and renal function in early-stage diabetic kidney disease.J. Coll. Physicians Surg. Pak.201929101009101110.29271/jcpsp.2019.10.100931564281
    [Google Scholar]
  208. SuF. XiaQ. Effects of valsartan and amlodipine tablets combined with α-lipoic acid on T-AOC, IL-6 and β2-MG levels in patients with diabetic nephropathy.Altern. Ther. Health Med.2023295126
    [Google Scholar]
  209. CaoX. ChenP. The effects of alprostadil combined with α-Lipoic acid in the treatment of senile diabetic nephropathy.Am. J. Transl. Res.2021139108231082934650761
    [Google Scholar]
  210. ZhangH. MuJ. DuJ. FengY. XuW. BaiM. ZhangH. Alpha-lipoic acid could attenuate the effect of chemerin-induced diabetic nephropathy progression.Iran. J. Basic Med. Sci.20212481107111634804428
    [Google Scholar]
  211. LiaoS. YangW. YuT. DaiL. LiuX. ZhangJ. ZhaoJ. LiuC. Establishment of a drug screening model for cardiac complications of acute renal failure.Biomolecules2021119137010.3390/biom1109137034572583
    [Google Scholar]
  212. AddorF. Beyond photoaging: Additional factors involved in the process of skin aging.Clin. Cosmet. Investig. Dermatol.20181143744310.2147/CCID.S17744830288075
    [Google Scholar]
  213. KrutmannJ. BoulocA. SoreG. BernardB.A. PasseronT. The skin aging exposome.J. Dermatol. Sci.201785315216110.1016/j.jdermsci.2016.09.01527720464
    [Google Scholar]
  214. HungC.F. ChenW.Y. AljuffaliI.A. LinY.K. ShihH.C. FangJ.Y. Skin aging modulates percutaneous drug absorption: The impact of ultraviolet irradiation and ovariectomy.Age (Omaha)20153722110.1007/s11357‑015‑9757‑125721687
    [Google Scholar]
  215. KimK. KimJ. KimH. SungG.Y. Effect of α-lipoic acid on the development of human skin equivalents using a pumpless skin-on-a-chip model.Int. J. Mol. Sci.2021224216010.3390/ijms2204216033671528
    [Google Scholar]
  216. KoçakA. UralC. HarmanciD. OktanM.A. AfaghA. SariogluS. YilmazO. BirlikM. AkdoganG.G. CavdarZ. Protective effects of alpha-lipoic acid on bleomycin-induced skin fibrosis through the repression of NADPH Oxidase 4 and TGF-β1/Smad3 signaling pathways.Hum. Exp. Toxicol.202241p. 0960327121106597510.1177/0960327121106597535187969
    [Google Scholar]
  217. ThirunavukkarasuV. NandhiniA.T.A. AnuradhaC.V. Fructose diet-induced skin collagen abnormalities are prevented by lipoic acid.Exp. Diabesity Res.20045423724410.1080/15438609050614815763937
    [Google Scholar]
  218. AibaT. KonoY. EtohT. KawanoY. OshimaY. InomataM. Efficacy of cooling therapy and α-lipoic acid derivative against chemotherapy-induced alopecia in an animal model.Cancer Sci.202311431007101410.1111/cas.1563936337052
    [Google Scholar]
  219. de BengyA.F. DecorpsJ. MartinL.S. PagnonA. ChevalierF.P. Sigaudo-RousselD. FromyB. Alpha-lipoic acid supplementation restores early age-related sensory and endothelial dysfunction in the skin.Biomedicines20221011288710.3390/biomedicines1011288736359407
    [Google Scholar]
  220. IsaacV.L.B. Chiari-AndréoB.G. MartoJ.M. MoraesJ.D.D. LeoneB.A. CorrêaM.A. RibeiroH.M. Rheology as a tool to predict the release of alpha-lipoic acid from emulsions used for the prevention of skin aging.BioMed Res. Int.201520151810.1155/2015/81865626788510
    [Google Scholar]
  221. KubotaY. MusashiM. NagasawaT. ShimuraN. IgarashiR. YamaguchiY. Novel nanocapsule of α-Lipoic acid reveals pigmentation improvement: α-Lipoic acid stimulates the proliferation and differentiation of keratinocyte in murine skin by topical application.Exp. Dermatol.201928S1Suppl. 1556310.1111/exd.1382830698882
    [Google Scholar]
  222. SherifS. BendasE.R. BadawyS. The clinical efficacy of cosmeceutical application of liquid crystalline nanostructured dispersions of alpha lipoic acid as anti-wrinkle.Eur. J. Pharm. Biopharm.201486225125910.1016/j.ejpb.2013.09.00824056055
    [Google Scholar]
  223. DaviesS. ContriR.V. GuterresS.S. PohlmannA.R. GuerreiroI.C.K. Simultaneous nanoencapsulation of lipoic acid and resveratrol with improved antioxidant properties for the skin.Colloids Surf. B Biointerfaces202019211102310.1016/j.colsurfb.2020.11102332361374
    [Google Scholar]
  224. XiaN. LiuT. WangQ. XiaQ. BianX. In vitro evaluation of α-Lipoic acid-loaded lipid nanocapsules for topical delivery.J. Microencapsul.201734657158110.1080/02652048.2017.136785228830289
    [Google Scholar]
  225. National Library of MedicineAnti-oxidant treatment of Alzheimer's disease.2009Available From: https://clinicaltrials.gov/study/NCT00117403?cond=Alzheimer%27s%20Disease&term=lipoic%20acid&rank=4
  226. National Library of MedicineFish oil and alpha lipoic acid in treating Alzheimer's disease.2017Available From: https://clinicaltrials.gov/study/NCT00090402?cond=neurodegenerative&term=lipoic%20acid&rank=2
  227. National Library of MedicineLipoic acid and omega-3 fatty acids for Alzheimer's disease.2017Available From: https://clinicaltrials.gov/study/NCT01058941?cond=neurodegenerative&term=lipoic%20acid&rank=1
  228. National Library of MedicineAlpha-lipoic Acid/​L-acetyl carnitine for progressive supranuclear palsy.2017Available From: https://clinicaltrials.gov/study/NCT01537549?cond=Neurodegeneration&term=lipoic%20acid&rank=1
  229. National Library of MedicineEvaluation of efficacy and safety of add-on alpha-lipoic acid on migraine prophylaxis in adolescent population.2023Available From: https://clinicaltrials.gov/study/NCT04064814
  230. National Library of MedicinePostoperative alpha lipoic acid in the carpal tunnel syndrome: A randomized controlled trial.2015Available From: https://clinicaltrials.gov/study/NCT01895621?cond=neurodegenerative&term=lipoic%20acid&rank=5
  231. National Library of MedicineAlpha-lipoic acid in patients at risk for paclitaxel induced neuropathy.2014Available From: https://clinicaltrials.gov/study/NCT01313117?cond=Cancer&term=lipoic%20acid&rank=10
  232. National Library of MedicineEffect of alpha lipoic acid on obesity related comorbidities.2010Available From: https://clinicaltrials.gov/study/NCT00994513?cond=Diabetes&term=lipoic%20acid&rank=7
  233. National Library of MedicineEffects of lipoic acid on Oxidative, inflammatory and functional markers in asthmatic patients.Available From: https://clinicaltrials.gov/study/NCT01221350?cond=Antioxidant%20Effect&term=lipoic%20acid&rank=3 2010
  234. National Library of MedicineAlpha-lipoic acid Reduces left ventricular mass in normotensive type 2 diabetic patients with coronary artery disease.2015Available From: https://clinicaltrials.gov/study/NCT01877590?cond=Diabetes&term=lipoic%20acid&rank=8
  235. National Library of MedicineThe effects of lipoic acid on glycaemic control in Type 2 Diabetes.2010Available From: https://clinicaltrials.gov/study/NCT00398892?cond=Diabetes&term=lipoic%20acid&rank=1
  236. National Library of MedicineAlpha lipoic acid and diabetes mellitus: Potential effects on peripheral neuropathy.2020Available From: https://clinicaltrials.gov/study/NCT04322240?cond=Diabetes&term=lipoic%20acid&rank=10
  237. National Library of MedicineClinical trial on alpha lipoic acid in diabetic macular edema (RETIPON).2010Available From: https://clinicaltrials.gov/study/NCT01208948?cond=Diabetes&term=lipoic%20acid&rank=2
  238. National Library of MedicineAlpha lipoic acid and Polycystic Ovary Syndrome.2013Available From: https://clinicaltrials.gov/study/NCT00505427?cond=Cancer&term=lipoic%20acid&rank=6
  239. National Library of MedicineThe effect of α-lipoic acid treatment in patient with cardiac autonomic neuropathy (CANON).2013Available From: https://clinicaltrials.gov/study/NCT02056366?cond=Diabetes&term=lipoic%20acid&page=2&rank=13
  240. National Library of MedicineAlpha-lipoic acid in breast cancer patients.2021Available From: https://clinicaltrials.gov/study/NCT03908528?cond=skin&term=lipoic%20acid&rank=1
  241. ShintoL. QuinnJ. MontineT. DodgeH.H. WoodwardW. Baldauf-WagnerS. WaichunasD. BumgarnerL. BourdetteD. SilbertL. KayeJ. A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer’s disease.J. Alzheimers Dis.201338111112010.3233/JAD‑13072224077434
    [Google Scholar]
  242. PuliappadambH.M. SatpathyA.K. MishraB.R. MaitiR. JenaM. Evaluation of safety and efficacy of add-on alpha-lipoic acid on migraine prophylaxis in an adolescent population: A randomized controlled trial.J. Clin. Pharmacol.202363121398140710.1002/jcph.233137563914
    [Google Scholar]
  243. WeridaR.H. ElshafieyR.A. GhoneimA. ElzawawyS. MostafaT.M. Role of alpha-lipoic acid in counteracting paclitaxel- and doxorubicin-induced toxicities: A randomized controlled trial in breast cancer patients.Support. Care Cancer20223097281729210.1007/s00520‑022‑07124‑035596774
    [Google Scholar]
  244. BilskaA. WłodekL. Lipoic acid - the drug of the future?Pharmacol. Rep.200557557057716227639
    [Google Scholar]
  245. Rezaei KelishadiM. Alavi NaeiniA. AskariG. KhorvashF. HeidariZ. The efficacy of alpha-lipoic acid in improving oxidative, inflammatory, and mood status in women with episodic migraine in a randomised, double-blind, placebo-controlled clinical trial.Int. J. Clin. Pract.2021759e1445510.1111/ijcp.1445534105866
    [Google Scholar]
  246. ÖztürkG. DemiryurekB.E. Efficacy of intravenous alpha lipoic acid in the treatment of neuropatic pain due to carpal tunnel syndrome.Ideggyogy. Sz.2023769-1031932610.18071/isz.76.031937782062
    [Google Scholar]
  247. QuesterK. Rodríguez-GonzálezS. González-DávalosL. Lozano-FloresC. González-GallardoA. Zapiain-MerinoS.J. ShimadaA. MoraO. Vazquez-DuhaltR. Chitosan nanoparticles containing lipoic acid with antioxidant properties as a potential nutritional supplement.Animals (Basel)202212441710.3390/ani1204041735203125
    [Google Scholar]
  248. WangJ. TangJ. ZhouX. XiaQ. Physicochemical characterization, identification and improved photo-stability of α-Lipoic acid-loaded nanostructured lipid carrier.Drug Dev. Ind. Pharm.201440220121010.3109/03639045.2012.75390123336811
    [Google Scholar]
  249. LuX. HeZ. XiaoX. WeiX. SongX. ZhangS. Natural antioxidant-based nanodrug for atherosclerosis treatment.Small20231949230345910.1002/smll.20230345937607320
    [Google Scholar]
  250. CalabreseE.J. AgathokleousE. DhawanG. KapoorR. CalabreseV. Protective effects of alpha lipoic acid (ALA) are mediated by hormetic mechanisms.Food Chem. Toxicol.202317711380510.1016/j.fct.2023.11380537169059
    [Google Scholar]
  251. ZhouZ. LiuC. WanX. FangL. Development of a w/o emulsion using ionic liquid strategy for transdermal delivery of anti – aging component α – lipoic acid: Mechanism of different ionic liquids on skin retention and efficacy evaluation.Eur. J. Pharm. Sci.202014110504210.1016/j.ejps.2019.10504231634554
    [Google Scholar]
  252. DerosaG. D’AngeloA. PretiP. MaffioliP. Safety and efficacy of alpha lipoic acid during 4 years of observation: A retrospective, clinical trial in healthy subjects in primary prevention.Drug Des. Devel. Ther.2020145367537410.2147/DDDT.S28080233299302
    [Google Scholar]
  253. JibrilA.T. JayediA. Shab-BidarS. Efficacy and safety of oral alpha-lipoic acid supplementation for type 2 diabetes management: A systematic review and dose–response meta-analysis of randomized trials.Endocr. Connect.20221110e22032210.1530/EC‑22‑032236006850
    [Google Scholar]
  254. Abdel HamidD.Z. NienaaY.A. MostafaT.M. Alpha-lipoic acid improved anemia, erythropoietin resistance, maintained glycemic control, and reduced cardiovascular risk in diabetic patients on hemodialysis: A multi-center prospective randomized controlled study.Eur. Rev. Med. Pharmacol. Sci.20222672313232935442486
    [Google Scholar]
  255. EspositoC. Ugo GarzarellaE. SantarcangeloC. Di MinnoA. DacremaM. SacchiR. PiccinocchiG. PiccinocchiR. DagliaM. Safety and efficacy of alpha-lipoic acid oral supplementation in the reduction of pain with unknown etiology: A monocentric, randomized, double-blind, placebo-controlled clinical trial.Biomed. Pharmacother.202114411230810.1016/j.biopha.2021.11230834649217
    [Google Scholar]
  256. BhattiF. MankheyR.W. AsicoL. QuinnM.T. WelchW.J. MaricC. Mechanisms of antioxidant and pro-oxidant effects of α-Lipoic acid in the diabetic and nondiabetic kidney.Kidney Int.20056741371138010.1111/j.1523‑1755.2005.00214.x15780089
    [Google Scholar]
  257. MaschioM. ZarablaA. MaialettiA. MarchesiF. GiannarelliD. GumenyukS. PisaniF. RenziD. GalièE. MengarelliA. Prevention of bortezomib-related peripheral neuropathy with docosahexaenoic acid and α-Lipoic acid in patients with multiple myeloma: Preliminary data.Integr. Cancer Ther.20181741115112410.1177/153473541880375830295079
    [Google Scholar]
  258. NguyenH. Alpha-Lipoic Acid.Treasure Island (FL)StatPearls2023
    [Google Scholar]
  259. GattiM. IppolitiI. PoluzziE. AntonazzoI.C. MoroP. MorettiU. Menniti-IppolitoF. MazzantiG. De PontiF. RaschiE. Assessment of adverse reactions to α-Lipoic acid containing dietary supplements through spontaneous reporting systems.Clin. Nutr.2020403117932778460
    [Google Scholar]
  260. LiZ. SuY. YiD. WuC. FangW. WangC. Analysis of the clinical characteristics of insulin autoimmune syndrome induced by alpha-lipoic acid.J. Clin. Pharm. Ther.20214651295130010.1111/jcpt.1342733821530
    [Google Scholar]
  261. SementinaA. CierzniakowskiM. RogalskaJ. PiechowiakI. SpichalskiM. AraszkiewiczA. A novel approach to alpha-lipoic acid therapy in the treatment of diabetic peripheral neuropathy.J. Med. Sci.202290e71410.20883/medical.e714
    [Google Scholar]
/content/journals/cmc/10.2174/0109298673300496240416114827
Loading
/content/journals/cmc/10.2174/0109298673300496240416114827
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test